Related Experiment Videos
Loop diuretics block calcium currents in cardiac cells
1Department of Physiology, Hebrew University Medical School, Jerusalem, Israel.
Insights
Loop diuretics like furosemide directly impact heart function by reducing calcium currents, independent of their kidney effects. This finding suggests a novel mechanism for how these common drugs alleviate heart failure and hypertension.
Area of Science:
- Cardiology
- Pharmacology
- Nephrology
Background:
- Loop diuretics are essential treatments for heart failure and hypertension.
- Their primary mechanism involves inhibiting sodium reabsorption in the kidneys via the Na/K/Cl cotransporter.
- Emerging evidence suggests potential direct cardiovascular effects preceding diuretic action.
Purpose of the Study:
- To investigate the direct effects of loop diuretics, specifically bumetanide and furosemide, on cardiac ion channels.
- To determine if these drugs directly influence cardiac function independently of their diuretic properties.
Main Methods:
- Electrophysiological recordings were performed on rabbit ventricular and atrial myocytes.
- The effects of bumetanide and furosemide on L-type calcium currents were measured.
- The onset and reversibility of the drug effects were analyzed.
Main Results:
- Bumetanide and furosemide significantly reduced cardiac L-type calcium currents in a reversible manner.
- The observed effect occurred at micromolar concentrations and within 1-2 seconds.
- This rapid onset suggests a direct interaction with the calcium channels, independent of cotransporter inhibition.
Conclusions:
- Loop diuretics, bumetanide and furosemide, exert a direct inhibitory effect on cardiac L-type calcium currents.
- This direct action on cardiac myocytes may contribute to their therapeutic efficacy in managing hypertension and heart failure.
- The findings highlight a potential dual mechanism of action for loop diuretics, involving both renal and direct cardiac effects.
Abstract:
Loop diuretics are widely used drugs; serving to alleviate congestive heart failure and hypertension. Their mechanism of action is considered to be an inhibition of sodium retention in the kidneys, by a block of the Na/K/Cl cotransporter. The ensuing natriuresis and diuresis reduces blood pressure and alleviates congestive heart failure. Several earlier reports suggested direct cardiovascular effects, partly preceding the onset of diuresis. In the present study, evidence is presented for a direct action of two loop diuretic agents, bumetanide and furosemide, on cardiac L-type calcium currents in rabbit ventricular and atrial myocytes. This current is reversibly reduced by micromolar concentrations of these drugs. The onset of this effect can be observed within 1-2s, which could indicate a direct action on the calcium channel, independent of secondary effects subsequent to inhibition of the cotransporter. Thus, part of the therapeutic effects of the loop diuretics may be achieved through a direct reduction of cardiac output.